Loading
Latest filing published 01 Mar 2017 for WaferGen Bio-systems, Inc., €28k.
No signal scores available.
Michael P. Henighan discloses dealings in WaferGen Bio-systems, Inc. to SEC (Form 4). In total, 2 filings cover trades dated from 29 April 2015 to 28 February 2017.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 1 March 2017: a transaction of €28k, in WaferGen Bio-systems, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations